Filing Details
- Accession Number:
- 0001562180-17-000278
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-19 16:01:12
- Reporting Period:
- 2017-01-17
- Filing Date:
- 2017-01-19
- Accepted Time:
- 2017-01-19 16:01:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1557883 | Dermira Inc. | DERM | Pharmaceutical Preparations (2834) | 273267680 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1620520 | M. Christopher Griffith | C/O Dermira, Inc. 275 Middlefield Road, Suite 150 Menlo Park CA 94025 | Vp Corp. Dev. & Strategy | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-01-17 | 1,016 | $1.22 | 46,129 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-01-17 | 287 | $1.74 | 46,416 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-01-17 | 1,103 | $28.94 | 45,313 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-01-17 | 200 | $30.08 | 45,113 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Options (Right to buy) | Disposition | 2017-01-17 | 287 | $0.00 | 287 | $1.74 |
| Common Stock | Employee Stock Options (Right to buy) | Disposition | 2017-01-17 | 1,016 | $0.00 | 1,016 | $1.22 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,600 | 2024-02-06 | No | 4 | M | Direct | |
| 48,594 | 2023-01-03 | No | 4 | M | Direct |
Footnotes
- These shares include prior ESPP purchases.
- These trades were made pursuant to a Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades at prices ranging from $28.56 to $29.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $30.04 to $30.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- 25% of the total shares underlying the option vested and became exercisable on February 9, 2015 (the one-year anniversary of the vesting commencement date) and 1/48 of the total shares underlying the option vest and become exercisable each month thereafter, subject to the continuing employment of the Reporting person on the applicable vesting date.
- 25% of the total shares underlying the option vested and became exercisable on January 4, 2014 (the one-year anniversary of the vesting commencement date) and 1/48 of the total shares underlying the option vest and become exercisable each month thereafter, subject to the continuing employment of the Reporting person on the applicable vesting date.
Billionaire Hedge Funds
